Furthermore, because the lack of prognostic value for FOXP3 was a surprising finding due to previous reports on their adverse impact in tumor progression, we performed an additional analysis whereby total and stromal CD8 and FOXP3 expression were combined together. This evidence concerns the gene CD8A and neoplasm.